3rd Peptide-Based Therapeutics Summit 2026 Hilton Boston Logan Airport, Boston
Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy.
To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation of peptide discoveries through development and towards life-saving treatments.
![]()
⌛ Event Dates & Venue
💸 Website & Tickets
Go to Event Website
Drug Developer - Conference + 2 Workshops: USD 4397.00, Academic - Conference + 2 Workshops: USD 3797.00, Solution Provider - Conference + 2 Workshops: USD 5297.00, Drug Developer - Conference + 1 Workshop: USD 3748.00, Academic - Conference + 1 Workshop: USD 3248.00, Solution Provider - Conference + 1 Workshop: USD 4548.00, Drug Developer - Conference Only: USD 3099.00, Academic - Conference Only: USD 2699.00, Solution Provider - Conference Only: USD 3799.00
Advertisements
